GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Cash Flow from Financing

ARSUF (Fagron) Cash Flow from Financing : $-80.4 Mil (TTM As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Fagron Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the six months ended in Jun. 2024, Fagron paid $0.0 Mil more to buy back shares than it received from issuing new shares. It spent $1.6 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $16.8 Mil paying cash dividends to shareholders. It spent $10.4 Mil on other financial activities. In all, Fagron spent $28.8 Mil on financial activities for the six months ended in Jun. 2024.


Fagron Cash Flow from Financing Historical Data

The historical data trend for Fagron's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Cash Flow from Financing Chart

Fagron Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.98 -64.61 -69.66 14.67 -81.00

Fagron Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.73 -39.17 -35.25 -45.52 -34.89

Fagron Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Fagron's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Fagron's Cash from Financing for the quarter that ended in Jun. 2024 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-80.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fagron  (OTCPK:ARSUF) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Fagron's issuance of stock for the six months ended in Jun. 2024 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Fagron's repurchase of stock for the six months ended in Jun. 2024 was $0.0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Fagron's net issuance of debt for the six months ended in Jun. 2024 was $-1.6 Mil. Fagron spent $1.6 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Fagron's net issuance of preferred for the six months ended in Jun. 2024 was $0.0 Mil. Fagron paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Fagron's cash flow for dividends for the six months ended in Jun. 2024 was $-16.8 Mil. Fagron spent $16.8 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Fagron's other financing for the six months ended in Jun. 2024 was $-10.4 Mil. Fagron spent $10.4 Mil on other financial activities.


Fagron Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Fagron's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Fagron Business Description

Traded in Other Exchanges
Address
Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB
Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.

Fagron Headlines

From GuruFocus

Fagron NV At Capital Markets Day Transcript

By GuruFocus Research 02-12-2024

Q3 2023 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q3 2022 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q4 2020 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q1 2019 Fagron NV Corporate Sales Call Transcript

By GuruFocus Research 02-12-2024

Q3 2021 Fagron NV Trading Statement Call Transcript

By GuruFocus Research 02-12-2024

Q2 2021 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2019 Fagron NV Earnings Call Transcript

By GuruFocus Research 02-12-2024

Q2 2024 Fagron NV Earnings Call Transcript

By GuruFocus News 10-09-2024